生物制剂治疗银屑病患者的抗炎效应:一项前瞻性队列FDG PET研究
该前瞻性队列研究纳入34例银屑病关节炎和/或皮肤银屑病患者(生物制剂组11例、非生物制剂组13例)及10例对照,用FDG PET测量升主动脉最病变段靶本比(TBRmax)评估血管炎症,用82Rb PET评估左心室心肌血流储备(MFR)。生物制剂组胸主动脉摄取显著下降(ΔTBRmax:-.46±.55),非生物制剂组为.23±.67;对生物制剂有应答者MFR维持,无应答者则未维持。
要点
- 生物制剂组胸主动脉FDG摄取下降(ΔTBRmax -.46±.55),非生物制剂组为.23±.67。
- 对生物制剂有显著抗炎应答者维持了MFR,无应答者未维持。
- 共纳入34例:生物制剂组11例、非生物制剂组13例、对照10例。
核心结论
- 在接受生物制剂治疗的银屑病患者队列中,胸主动脉FDG摄取在研究期间下降。
- FDG PET显示显著抗炎应答的患者维持了MFR,而无应答者未维持。
研究设计与样本
- 前瞻性队列FDG PET研究,纳入银屑病关节炎和/或皮肤银屑病患者及对照,共34例:生物制剂组11例、非生物制剂组13例、对照10例。
- 用FDG PET测量升主动脉最病变段靶本比(TBRmax)评估血管炎症,用82Rb PET评估左心室MFR。
主要发现
- 生物制剂组胸主动脉摄取显著下降,ΔTBRmax为-.46±.55;非生物制剂组ΔTBRmax为.23±.67。
- 对生物制剂有应答者维持了MFR,无应答者未维持。
关键数值与推荐
- 血管炎症以FDG PET升主动脉最病变段TBRmax评估。
- 心肌血流储备以82Rb PET测量的左心室MFR评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: The aim of the study was to evaluate the changes in central vascular inflammation measured by FDG PET and myocardial blood flow reserve (MFR) determined by 82Rb PET following therapy with biologic agents for 6 months in patients with psoriatic arthritis (PsA) and/or cutaneous psoriasis (PsO) (group 1) and compare with PsO subjects receiving non-biologic therapy (group 2) and controls (group 3). METHODS AND RESULTS: Target-to-background ratio (TBR) by FDG PET in the most diseased segment of the ascending aorta (TBRmax) was measured to assess vascular inflammation. 82Rb PET studies were used to assess changes in left ventricular MFR. A total of 34 participants were enrolled in the study (11 in group 1, 13 in group 2, and 10 controls). A significant drop in the thoracic aorta uptake was observed in the biologic-treated group (ΔTBRmax: - .46 ± .55) compared to the PsO group treated with non-biologic therapy (ΔTBRmax: .23 ± .67). Those showing response to biologic agents maintained MFR compared to who showed no response. CONCLUSION: In a cohort of psoriasis patients treated with biologics, FDG uptake in the thoracic aorta decreased over the study period. Patients who demonstrated a significant anti-inflammatory response on FDG PET imaging maintained their MFR compared to non-responders.
引用
- Boczar KE, Beanlands RS, Glassman SJ, et al. Anti-inflammatory effect of biologic therapy in patients with psoriatic disease: A prospective cohort FDG PET study. J Nucl Cardiol. 2023. PMID: 36754934. doi:10.1007/s12350-023-03204-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。